Clinical Trial Update: A Pilot Study on Raltegravir, Tenofovir and Emtricitabine for Peri-exposure Prophylaxis for HIV Infection [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating a combination of raltegravir, tenofovir, and emtricitabine for peri-exposure prophylaxis to prevent HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Emtricitabine (Emtricitabine)
• Raltegravir (raltegravir)
• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: Projeto Praça Onze | Conditions: Infection, HIV | Phase 3 | Status: UNKNOWN